Requisites for successful theranostics with radionuclide-based reporter gene imaging

Journal of Drug Targeting

Volumn 22, Issue 4, 2014, Pages 295-303

  Ahn, Byeong Cheol ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Gene therapy; Molecular imaging; Radionuclide; Reporter gene; Theranostics; Transcriptional targeting; Transductional targeting

Indexed keywords

(3 IODOBENZYL)GUANIDINE; (3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; 1 (2' DEOXY 2' FLUORO BETA DEXTRO ARABINOFURANOSYL) 5 ETHYLURIDINE F 18; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 2' DEOXY 2' FLUORO 5 IODO 1 [BETA] DEXTRO ARABINOFURANOSYLURACIL F 18; 5 (2 BROMOVINYL) 2' DEOXYURIDINE; 9 (4 FLUORO 3 HYDROXYMETHYLBUTYL)GUANINE F 18; BROMINE 76; COPPER 64; DEOXY 2' FLUORO DEXTRO ARABINOFURANOSYLTHYMIDINE C 11; DEOXY 2' FLUORO DEXTRO ARABINOFURANOSYLTHYMIDINE F 18; FLUCYTOSINE; FLUORINE 18; GANCICLOVIR; GASTRIN RELEASING PEPTIDE; INDIUM 111; IODINE 123; IODINE 124; IODINE 131; METABROMOBENZYLGUANIDINE BR 76; NEUROMEDIN B; PENCICLOVIR; PENTETREOTIDE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; TETRAFLUOROBORATE; THYMIDINE; TRETAZICAR; UNCLASSIFIED DRUG; UNINDEXED DRUG; COTRANSPORTER; SODIUM IODIDE SYMPORTER;

ECHOGRAPHY; ENHANCER REGION; FLUORESCENCE IMAGING; GAMMA RADIATION; GENE ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HUMAN; IMAGE QUALITY; ISOTOPE LABELING; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROMOTER REGION; RADIATION DOSE; RADIOCHEMISTRY; REPORTER GENE; REVIEW; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; DIAGNOSTIC USE; GENE TRANSFER; GENETICS; HYPERTHYROIDISM; PROCEDURES; THYROID NEOPLASMS;

ANIMALS; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC THERAPY; HUMANS; HYPERTHYROIDISM; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SYMPORTERS; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84898411133     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2013.878940     Document Type: Review

References (43)

1. Bhaumik S. Advances in imaging gene-directed enzyme prodrug therapy. Curr Pharm Biotechnol 2011;12:497-507.
2. Ahn BC. Applications of molecular imaging in drug discovery and development process. Curr Pharm Biotechnol 2011;12:459-68.
3. Ray P, De A. Reporter gene imaging in therapy and diagnosis. Theranostics 2012;2:333-4.
4. Kang JH, Chung JK. Molecular-genetic imaging based on reporter gene expression. J Nucl Med 2008;49:164S-79S.
5. Ahn BC, Ronald JA, Kim YI, et al. Potent, tumor-specific gene expression in an orthotopic hepatoma rat model using a Survivin-targeted, amplifiable adenoviral vector. Gene Ther 2011;18:606-12.
6. Seo JH, Jeon YH, Lee YJ, et al. Trafficking macrophage migration using reporter gene imaging with human sodium iodide symporter in animal models of inflammation. J Nucl Med 2010;51:1637-43.
7. Jeon YH, Lee HW, Lee YL, et al. Combined E7-dendritic cell-based immunotherapy and human sodium/iodide symporter radioiodine gene therapy with monitoring of antitumor effects by bioluminescent imaging in a mouse model of uterine cervical cancer. Cancer Biother Radiopharm 2011;26:671-9.
8. Yaghoubi SS, Campbell DO, Radu CG, Czernin J. Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications. Theranostics 2012;2:374-91.
9. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature 2008;452:580-9.
10. Ahn BC. Sodium iodide symporter for nuclear molecular imaging and gene therapy: from bedside to bench and back. Theranostics 2012;2:392-402.
11. Sosnovik DE, Wu JC. Molecular imaging of stem cells in myocardial infarction. Shelton: PMPH-USA; 2010.
12. Robson T, Hirst DG. Transcriptional targeting in cancer gene therapy. J Biomed Biotechnol 2003;2003:110-37.
13. Schuldiner M, Itskovitz-Eldor J, Benvenisty N. Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells 2003;21:257-65.
14. Knoepfler PS. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 2009;27:1050-6.
15. Cao F, Lin S, Xie X, et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 2006;113:1005-14.
16. Ziessman HA, O'Malley JP, Thrall JH. Nuclear medicine: the requisites in radiology. Philadelphia (PA): Elsevier Mosby; 2006.
17. Hamoudeh M, Kamleh MA, Diab R, Fessi H. Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer. Adv Drug Deliv Rev 2008;60:1329-46.
18. Sgouros G. Alpha-particles for targeted therapy. Adv Drug Deliv Rev 2008;60:1402-6.
19. Srivastava SC. The role of electron-emitting radiopharmaceuticals in the palliative treatment of metastatic bone pain and for radiosynovectomy: applications of conversion electron emitter Tin-117m. Brazilian Arch Biol Technol 2007;50:49-62.
20. Limouris GS, Chatziioannou A, Kontogeorgakos D, et al. Selective hepatic arterial infusion of In-111-DTPA-Phe1-octreotide in neuroendocrine liver metastases. Eur J Nucl Med Mol Imaging 2008;35:1827-37.
21. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19: 1167-214.
22. Bhang HE, Pomper MG. Cancer imaging: gene transcription-based imaging and therapeutic systems. Int J Biochem Cell Biol 2012;44: 684-9.
23. Fang B, Roth J. Adenovector-mediated cancer gene therapy. Totowa: Humana Press Inc.; 2007.
24. Kamimura K, Suda T, Zhang G, Liu D. Advances in gene delivery systems. Pharmaceut Med 2011;25:293-306.
25. Duarte S, Carle G, Faneca H, et al. Suicide gene therapy in cancer: where do we stand now? Cancer Lett 2012;324:160-70.
26. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003;4: 346-58.
27. Yamamoto M, Curiel DT. Tumor targeting-retargeted adenovirus. Totowa: Humana Press; 2007.
28. Douglas JT, Rogers BE, Rosenfeld ME, et al. Targeted gene delivery by tropism-modified adenoviral vectors. Nat Biotechnol 1996;14:1574-8.
29. Witlox MA, Lamfers ML, Wuisman PI, et al. Evolving gene therapy approaches for osteosarcoma using viral vectors: review. Bone 2007;40:797-812.
30. Lee P, Huang L. Nonviral vector systems. Totowa: Humana Press Inc.; 2007.
31. Nimesh S. Potential implications of nanoparticle characterization on in vitro and in vivo gene delivery. Ther Deliv 2012;3:1347-56.
32. Ogris M, Wagner E. Targeting tumors with non-viral gene delivery systems. Drug Discov Today 2002;7:479-85.
33. Cho K, Wang X, Nie S, et al. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008;14:1310-16.
34. Walker GF, Wagner E. Nonviral vector systems for cancer gene therapy. Totowa: Humana Press; 2005.
35. Kim KI, Lee YJ, Lee TS, et al. In vitro radionuclide therapy and in vivo scintigraphic imaging of alpha-fetoprotein-producing hepatocellular carcinoma by targeted sodium iodide symporter gene expression. Nucl Med Mol Imaging 2013;7:1-8.
36. Ong CT, Corces VG. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nature reviews. Genetics 2011;12:283-93.
37. Dorer DE, Nettelbeck DM. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis. Adv Drug Deliv Rev 2009;61:554-71.
38. Ray S, Paulmurugan R, Patel MR, et al. Noninvasive imaging of therapeutic gene expression using a bidirectional transcriptional amplification strategy. Mol Ther 2008;16:1848-56.
39. Ray P, Gambhir SS. Multimodality imaging of reporter genes. In: Gambhir SS, Yaghoubi SS, eds. Molecular imaging with reporter genes. NY: Cambridge University Press; 2010:113-26.
40. Waerzeggers Y, Monfared P, Viel T, et al. Methods to monitor gene therapy with molecular imaging. Methods 2009;48:146-60.
41. Lee SW, Lee YL, Lee YJ, et al. Enhanced antitumor effects by combination gene therapy using MDR1 gene shRNA and HSV1-tk in a xenograft mouse model. Cancer Lett 2010;291:83-9.
42. Kim JE, Ahn BC, Hwang MH, et al. Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma. J Nucl Med 2011;52:1756-63.
43. Kim HW, Kim JE, Hwang MH, et al. Enhancement of natural killer cell cytotoxicity by sodium/iodide symporter gene-mediated radio-iodine pretreatment in breast cancer cells. PLoS One 2013;8: e70194.